250 related articles for article (PubMed ID: 22658906)
21. Radiation therapy in the management of breast cancer.
Yang TJ; Ho AY
Surg Clin North Am; 2013 Apr; 93(2):455-71. PubMed ID: 23464696
[TBL] [Abstract][Full Text] [Related]
22. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
23. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
Shelley Hwang E; Thompson A
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376162
[No Abstract] [Full Text] [Related]
24. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
25. [Controversies in breast conservation treatment for breast cancer].
Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
[TBL] [Abstract][Full Text] [Related]
26. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: intraductal carcinoma.
Cutuli B
Cancer; 2000 Apr; 88(8):1976-7. PubMed ID: 10760777
[No Abstract] [Full Text] [Related]
27. Evolution of breast-conserving therapy for localized breast cancer.
Schnitt SJ; Harris JR
J Clin Oncol; 2008 Mar; 26(9):1395-6. PubMed ID: 18349387
[No Abstract] [Full Text] [Related]
28. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
[TBL] [Abstract][Full Text] [Related]
29. [Value of radiotherapy in breast cancer. Breast preservation rises to 80%].
Seegenschmiedt MH; Strittmatter HJ
MMW Fortschr Med; 2003 Jun; 145(25):26-30. PubMed ID: 12891848
[TBL] [Abstract][Full Text] [Related]
30. Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
Rourke LL; Hunt KK
Ann Surg; 2010 Apr; 251(4):592-4. PubMed ID: 20224366
[No Abstract] [Full Text] [Related]
31. Radiation Therapy Following Breast Conserving Surgery for Ductal Carcinoma in situ: Yes or No?
Stoleru LS; Stoleru S
Chirurgia (Bucur); 2017; 112(4):403-412. PubMed ID: 28862116
[TBL] [Abstract][Full Text] [Related]
32. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
33. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
34. Accelerated partial breast irradiation as a part of breast conservation therapy.
Arthur DW; Vicini FA
J Clin Oncol; 2005 Mar; 23(8):1726-35. PubMed ID: 15755981
[No Abstract] [Full Text] [Related]
35. [Treatment of intraductal carcinomas. 91 cases treated at Oscar-Lambret Center].
Patry-Lubeth MF; Giard S; Laurent JC
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(8):783-7. PubMed ID: 8636609
[TBL] [Abstract][Full Text] [Related]
36. Is radiotherapy needed after adequate local excision of localized DCIS?
Cutuli B
Int J Fertil Womens Med; 2004; 49(5):231-6. PubMed ID: 15633482
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
[TBL] [Abstract][Full Text] [Related]
39. Current controversies in the treatment of ductal carcinoma in situ of the breast.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
[TBL] [Abstract][Full Text] [Related]
40. Margins in DCIS: Does Residual Disease Provide an Answer?
Morrow M; Van Zee KJ
Ann Surg Oncol; 2016 Oct; 23(11):3423-3425. PubMed ID: 27165722
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
